Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.https://edrn.jpl.nasa.gov/publications/17121882-reprimo-methylation-is-a-potentialhttps://edrn.jpl.nasa.gov/logo.png
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.